Navitas Life Sciences

Configuring Oracle Argus to meet Device and Combination Product Regulatory Requirements

Our client, a top 5 global pharmaceutical company, was seeking support to develop a strategy to aid them in effectively managing the rollout of a combination product. In addition, they needed their system to support the management of any Adverse Events (AEs) reported on their devices and combination products. Their existing AE reporting process was not only manual, but also paper based. With combination products creating some confusion and over-reporting, coupled with upcoming regulations, this was untenable.

Read our latest case study and learn how we successfully configured Oracle Argus to meet Device and Combination Product Regulatory requirements, simplifying the technology landscape to enable better outcomes for our client while driving informed decisions.

Please complete the form to download the Case Study.

Please complete form to download PDF
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2021 Navitas Life Sciences | Privacy Policy